Targeted therapies for lung cancer patients with oncogenic driver molecular alterations

AC Tan, DSW Tan - Journal of Clinical Oncology, 2022 - ascopubs.org
Lung cancer has traditionally been classified by histology. However, a greater
understanding of disease biology and the identification of oncogenic driver alterations has …

Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations.

AC Tan, DSW Tan - Journal of Clinical Oncology: Official Journal of …, 2022 - europepmc.org
Lung cancer has traditionally been classified by histology. However, a greater
understanding of disease biology and the identification of oncogenic driver alterations has …

Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations

AC Tan, DSW Tan - Journal of Clinical Oncology, 2022 - ingentaconnect.com
Lung cancer has traditionally been classified by histology. However, a greater
understanding of disease biology and the identification of oncogenic driver alterations has …

Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations

AC Tan, DSW Tan - Journal of Clinical Oncology, 2022 - cir.nii.ac.jp
抄録< jats: p> Lung cancer has traditionally been classified by histology. However, a greater
understanding of disease biology and the identification of oncogenic driver alterations has …

Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations

AC Tan, DSW Tan - … of clinical oncology: official journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Lung cancer has traditionally been classified by histology. However, a greater
understanding of disease biology and the identification of oncogenic driver alterations has …